Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Transition Metal Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101163698B reveals efficient Pd-catalyzed coupling and reductive amination routes for 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide, offering significant supply chain advantages.
Patent CN107253967A enables transition-metal-free silylation for high-purity pharmaceutical intermediates. Achieve substantial cost reduction and supply chain reliability.
Patent CN110372633B details a transition-metal-free reduction method using NaBEt3H, offering significant cost reduction and simplified purification for API manufacturing.
Advanced ruthenium catalyst technology for cyclic carbonate hydrogenation. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Novel cobalt complexes enable selective internal alkyne hydroboration. Reduces reliance on precious metals for high-purity organoboron intermediate manufacturing.
Novel transition metal catalysis for 2-alkyl terephthalquinone. Enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110240579B reveals a novel catalytic route for polysubstituted gamma-butyrolactones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN105017043A reveals a mild synthesis method for alpha-amino acid derivatives. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN102947000A details Z-M-OR complexes for efficient C-H and N-H carboxylation. Enables sustainable API intermediate synthesis using renewable CO2 feedstock.
Novel Rh-catalyzed route for trifluoromethyl dihydrophenanthrenes. High yield, air-stable, scalable process for pharmaceutical intermediates.
Patent CN108640945B reveals a novel Ru/Ir-catalyzed direct C-H alkynylation of amides. This method eliminates directing groups, offering cost-effective routes for high-purity pharmaceutical intermediates.
Patent CN112250639B details a novel Ru/Cu-catalyzed route for heterocyclic arylamines. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN110066244B reveals a high-yield method for chiral tetrahydroquinoline synthesis using saturated aldehydes, offering >99% ee and significant cost reduction potential.
Patent CN110590823A reveals non-transition metal catalysis for borate derivatives. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable methods.
Patent CN113039175A reveals a scalable catalytic route for arylsulfonyl acrylonitriles, offering cost-effective and environmentally benign manufacturing solutions for global supply chains.
Novel patent CN106478525A details an iridium-catalyzed tandem synthesis of quinazolones using oximes, offering high atom economy and simplified purification for pharmaceutical intermediates.
Patent CN111217844B details a cost-effective 1,1-diboronation of olefins using Cp2ZrCl2. This method offers high atom economy and scalability for reliable pharmaceutical intermediate supply chains.
Patent CN107739322B details a novel Ir-catalyzed C-H activation route for sulfonamides. Discover cost-effective, high-yield manufacturing solutions for pharma and agrochemical intermediates.
Patent CN112047925B details a copper-catalyzed oxidative amination route for N-(aryl/heteroaryl) alkyl-diamides, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Efficient ruthenium-catalyzed method reduces costs and environmental load for high-purity pharmaceutical intermediates manufacturing supply chain.